SCHEMBL7984720

SCHEMBL7984720

Cc1ccc(Cn2cnc3[nH]c(-c4ccccc4)nc(=O)c32)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 2/20 0.48
PARN O95453 1/20 0.48
SMN1; SMN2 Q16637 5/20 0.43
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
HPGD P15428 2/20 0.41
PNP P00491 2/20 0.40
ALDH1A1 P00352 1/20 0.40
TNKS O95271 1/20 0.40
PARP1 P09874 1/20 0.40
TNKS2 Q9H2K2 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
ADORA2B P29275 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
ACP1 P24666 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975271 0.92 CNOT7 (0.56) CNOT7PARNSMN1; SMN2HPGDPNP
SCHEMBL7985827 0.90 CNOT7 (0.49) CNOT7PARNSMN1; SMN2CYP11B1CYP11B2
SCHEMBL7985065 0.90 CNOT7 (0.40) CNOT7PARNSMN1; SMN2CYP11B1CYP11B2
SCHEMBL7991406 0.89 CNOT7 (0.49) CNOT7PARNSMN1; SMN2CYP11B1CYP11B2
SCHEMBL7985168 0.89 KMT2A (0.46) CNOT7PARNCYP11B2ALDH1A1ACP1
SCHEMBL7986522 0.88 CNOT7 (0.48) CNOT7PARNSMN1; SMN2CYP11B1CYP11B2
SCHEMBL7985328 0.88 CNOT7 (0.51) CNOT7PARNSMN1; SMN2CYP11B1CYP11B2
SCHEMBL7984771 0.88 CNOT7 (0.47) CNOT7PARNSMN1; SMN2LMNAHTT
SCHEMBL7984427 0.88 HPGD (0.44) CNOT7PARNSMN1; SMN2CYP11B1CYP11B2
SCHEMBL7991600 0.88 ACP1 (0.42) CNOT7PARNSMN1; SMN2HTTACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed